European Medicines AgencyIEPMEMAHaematologyoncology
…t and ensure rational use.References and/or Acknowledgements 1. European Medicines Agency. Human medicines in 2024. EMA; 2024.2. Martínez-Barros H, et al…
11,350articles mentioning institutions
22,378institution mentions
9,137distinct institutions extracted
0%of mentions human-reviewed
All extracted institutions
Showing 421–480 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
Swedish Medical Products Agency4University of Toronto4eye banks4Aarhus University Hospital4Alder Hey Children’s Hospital4Amsterdam University Medical Centre4Anesth Analg4BCS4British Cardiovascular Intervention Society4Griffith University4IHI4IQVIA4Infectious Diseases Unit4NUH4OSF4Peking Union Medical College4Piraeus Medical4St. James’s Hospital4Sun Yat-sen University4US4University of California San Diego4University of California San Francisco4University of Sydney4University of Utah4ANSM4Aberdeen Royal Infirmary4Academic Search Complete4American Academy of Pediatrics4American Thoracic Society4Anhui Medical University4Asan Medical Center4Australia4BMC Nurs 20254BMJ Oncology4Beaumont Hospital4Belfast Heart Attack Centre4Beth Israel Deaconess Medical Center4Bristol Royal Infirmary4Cambridge University Hospitals4Centre4Charles River Laboratories4China Academy of Chinese Medical Sciences4Chinese BioMedical Literature Database4Clinical Trial Registry of India4Clinical Trials Ontario4Cochrane Database4Dana-Farber/Harvard Cancer Center4Doctors4EconLit4Eli Lilly4Eur Heart J4European Society for Medical Oncology4European Society of Gastrointestinal Endoscopy4First Affiliated Hospital of Sun Yat-Sen University4Fox Chase Cancer Center4Frontline Gastroenterology4GE HealthCare4GMC4German Stroke Registry4Ghent University4
Articles mentioning institutions
11,350 articles · page 257 of 946tertiary hospitaltransthyretin amyloidosisclinical trials
… Methods A retrospective observational study was conducted in a tertiary hospital including clinical trials on transthyretin amyloidosis from 201…
Glintt HealthCaretertiary hospitalinclisiranprimary hypercholesterolaemia
…btained from electronic health records and dispensing software (Glintt HealthCare )Results 54 patients (mean age 63.2±11.00 years; 63.46% male) w…
AGUQuetiapinedementiaBenzodiazepinesBladder antimuscarinicsStatinsSTOPPCogOpioids
…dy in a tertiary hospital.Inclusion criteria: Inpatients in the AGU with mild to very severe cognitive impairment in January 2024.D…
tertiary hospitalHospital Outpatient Clinicpaclitaxelcyclophosphamidehaematological malignanciesdocetaxeldoxorubicincarboplatinbevacizumaboncological treatment+1 more
… and Methods We conducted a prospective longitudinal study in a tertiary hospital. Adult patients receiving oncological treatment at the Hospital…
European Society for Blood and Marrow TransplantationEBMTaGVHDaGVHD-cumulative-incidenceacute renal failureacute graft-versus-host diseaseaGVHD-relatedPHARALLOaGVHD-free
…evention. International recommendations, such as those from the European Society for Blood and Marrow Transplantation (EBMT), emphasise the integration of clinical pharmacists into …
tertiary hospitalInternal Medicine Continuity of Care Unitdiabetes mellitusPharmaceutical interventionhypertensioninsulinchronic medication
…nd Methods A prospective, longitudinal study was conducted in a tertiary hospital, including all patients reconciled from January 2024 to August …
tertiary hospitalniraparibPARP-2PARP-1platinum-based chemotherapy
… received niraparib between January 2021 and December 2024 at a tertiary hospital. Progression-free survival (PFS) was the primary endpoint to as…
Clinical Pharmacy LaboratoryCerliponase alfaCLN2 diseaseNeuronal Ceroid Lipofuscinosis Type 2
…ment for subsequent administration.Conclusion and Relevance The Clinical Pharmacy Laboratory guarantees sterility and asepticity in the preparation of the d…
National Institute for Health and Care ExcellenceNICEHyperkalaemiaSodium zirconium cyclosilicateSZCNICEalternative therapies
… and therapeutic outcomes.References and/or Acknowledgements 1. National Institute for Health and Care Excellence (NICE). Sodium zirconium cyclosilicate for treating hyperkalaem…
Hospital Pharmacy DepartmentEndocrinology DepartmentketoconazolemetyraponeosilodrostatMetopironeCushing’s syndromehydroaltesoneEctopic Cushing’s Syndrome
…of pulmonary origin. The Endocrinology Department contacted the Hospital Pharmacy Department for joint therapeutic management. Metopirone was ruled out due …
hospitalmigrainegalcanezumabfremanezumabRimegepanteptinezumaberenumab
…round and Importance Migraine is one of the main pathologies in hospital pharmaceutical expenditure. Due to the high cost of these drugs…